Farallon Capital Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,000
Closed -$300K 154
2024
Q4
$300K Hold
1,000
﹤0.01% 113
2024
Q3
$406K Hold
1,000
﹤0.01% 111
2024
Q2
$321K Hold
1,000
﹤0.01% 116
2024
Q1
$334K Sell
1,000
-19,900
-95% -$6.08M ﹤0.01% 130
2023
Q4
$5.66M Sell
20,900
-153,500
-88% -$37.9M 0.03% 88
2023
Q3
$42.9M Sell
174,400
-88,000
-34% -$24.1M 0.2% 62
2023
Q2
$79.6M Buy
262,400
+105,800
+68% +$29.4M 0.4% 51
2023
Q1
$41.3M Buy
+156,600
New +$39.8M 0.23% 64

Other funds holding HCA

Farallon Capital Management's HCA Position: Q1 2025 in Review

Farallon Capital Management sold out of HCA Healthcare (HCA) in Q1 2025, closing a stake of 1,000 shares — an estimated $300K sold.

Farallon Capital Management first reported a position in HCA in Q1 2023 and held it in 8 quarters. The position peaked at $79.6M in Q2 2023. 1,224 funds tracked by Wall St. Rank hold HCA as of Q1 2025.

  • Farallon Capital Management reported no remaining HCA Healthcare position as of Q1 2025 after selling out during the quarter.
  • Farallon Capital Management sold 1,000 HCA Healthcare shares in Q1 2025, an estimated $300K.
  • Farallon Capital Management first reported a position in HCA Healthcare in Q1 2023 and held it in 8 quarters.
  • Farallon Capital Management's HCA Healthcare position peaked at $79.6M in Q2 2023.
  • 1,224 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2025.

Based on Farallon Capital Management's 13F filing for Q1 2025, filed 15 May 2025.